PET/CT in oncology - A major advance

Clinical Radiology

Volumn 60, Issue 11, 2005, Pages 1143-1155

  Wechalekar, K ^a   Sharma, B ^a   Cook, G J R ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

18F fluorodeoxyglucose; Oncology; Positron emission tomography computed tomography (PET CT)

Indexed keywords

CARBON 11; FLUORODEOXYGLUCOSE F 18; NITROGEN 13; OXYGEN 15;

ARTIFACT; BONE CANCER; CANCER LOCALIZATION; CANCER STAGING; CLINICAL PROTOCOL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIGESTIVE SYSTEM CANCER; EVIDENCE BASED MEDICINE; FOLLOW UP; GYNECOLOGIC CANCER; HIGH THROUGHPUT SCREENING; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; INTERMETHOD COMPARISON; LUNG CANCER; LYMPHOMA; OCCULT CANCER; ONCOLOGY; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING;

ARTIFACTS; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 27244435535     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2005.05.018     Document Type: Review

References (36)

1. O. Warburgh On the origin of cancer cells Science 123 1954 306-314
2. G.J. Cook E. Wegner I. Fogleman Pitfalls and artefacts in 18 FDG PET and PET/CT oncologic imaging Semin Nucl Med 34 2004 122-133
3. D.W. Townsend J.P. Carney J. Yap et al. PET/CT today and tomorrow J Nucl Med 45 Suppl 1 2004 4S-14S
4. G.W. Goerres E. Kamel B. Seifert et al. Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system J Nucl Med 43 2002 1469-1475
5. G.W. Goerres E. Kamel T.N. Heidelberg M.R. Schwitter C. Burger G.K. von Schulthess PET-CT image co-registration in the thorax: Influence of respiration Eur J Nucl Med Mol Imaging 29 2002 351-360
6. T.F. Hany H.C. Steinhart G.W. Goerres A. Buck G.K. von Schulthess PET diagnostic accuracy: Improvement with in-line PET-CT system: Initial results Radiology 225 2002 575-581
7. E. Dizendorf T.F. Hany A. Buck G.K. von Schulthess C. Burger Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies J Nucl Med 44 2003 732-738
8. C. Cohade R.L. Wahl Applications of positron emission tomography/ computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements Semin Nucl Med 33 2003 228-237
9. E.M. Kamel C. Burger A. Buck G.K. von Schulthess G.W. Goerres Impact of metallic dental implants on CT-based attenuation correction in a combined PET/CT scanner Eur Radiol 13 2003 724-728
10. G. Antoch L.S. Freudenberg T. Egelhof et al. Focal tracer uptake: A potential artifact in contrast-enhanced dual-modality PET/CT scans J Nucl Med 43 2002 1339-1342
11. P.E. Kinahan B.H. Hasegawa T. Beyer X-ray-based attenuation correction for positron emission tomography/computed tomography scanners Semin Nucl Med 33 2003 166-179
12. C. Cohade M. Osman Y. Nakamoto et al. Initial experience with oral contrast in PET/CT: Phantom and clinical studies J Nucl Med 44 2003 412-416
13. D. Lardinois W. Weder T.F. Hany et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 2003 2500-2507
14. N.G. Schaefer T. Hany C. Taverna et al. Non-Hodgkin lymphoma and Hodgkin disease: Coregistered FDG PET and CT at staging and restaging: Do we need contrast-enhanced CT? Radiology 232 2004 823-829
15. W.L. Wong K. Hussain E. Chevretton et al. Validation and clinical application of computer-combined computed tomography and positron emission tomography with 2-18F-fleuro-2-deoxy-d-glucose head and neck images Am J Surg 172 1996 628-632
16. G.W. Goerres G.K. von Schulthess H.C. Steinert Why most PET of lung and head-and-neck cancer will be PET/CT J Nucl Med 45 Suppl 1 2004 66S-71S
17. P.G. Kluetz C.C. Meltzer V.L. Villemagne et al. Combined PET/CT imaging in oncology. Impact on patient management Clin Positron Imaging 3 2000 223-230
18. A. Gutzeit G. Antoch H. Kuhl et al. Unknown primary tumors: Detection with dual-modality PET/CT: Initial experience Radiology 234 2004 227-234
19. S.S. Gambhir J. Czernin J. Schwimmer D.H. Silverman R.E. Coleman M.E. Phelps A tabulated summary of the FDG PET literature J Nucl Med 42 2001 1S-93S
20. K. Higashi Y. Ueda H. Seki et al. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma J Nucl Med 39 1998 1016-1020
21. H. Schoder S. Larson Positron emission tomography for prostate, bladder, and renal cancer Semin Nucl Med 34 2004 274-292
22. P. Armstrong D.J. Congleton S.W. Fountain et al. Guidelines on the selection of patients with lung cancer for surgery. British Thoracic Society and Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party Thorax 56 2001 89-108
23. G. Antoch J. Stattaus A.T. Nemat et al. Non-small cell lung cancer: Dual-modality PET/CT in preoperative staging Radiology 229 2003 526-533
24. Z. Keidar N. Haim L. Guralnik et al. PET/CT using 18F-FDG in suspected lung cancer recurrence: Diagnostic value and impact on patient management J Nucl Med 45 2004 1640-1646
25. C. Cohade M. Osman J. Leal R.L. Wahl Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma J Nucl Med 44 2003 1797-1803
26. M. Selzner T. Hany P. Wildbrett L. McCormack Z. Kadry P.A. Clavien Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 240 2004 1027-1034
27. E. Even-Sapir Y. Parag H. Lerman et al. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection Radiology 232 2004 815-822
28. G.W. Goerres R. Stupp G. Barghouth et al. The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: Long-term outcome of treatment with imatinib mesylate Eur J Nucl Med Mol 2004
29. G. Antoch J. Kanja S. Bauer et al. Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors J Nucl Med 45 2004 357-365
30. O. Israel M. Mom L. Guralnik et al. Is 18F-FDG PET/CT useful for imaging and management of patients with suspected occult recurrence of cancer J Nucl Med 45 2004 2045-2051
31. D. Grisaru B. Almog C. Levine et al. The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynecological malignancies Gynecol Oncol 94 2004 680-684
32. U. Metser H. Lerman A. Blank G. Lievshitz F. Bokstein E. Even-Sapir Malignant involvement of the spine: Assessment by 18F-FDG PET/CT J Nucl Med 45 2004 279-284
33. E. Even-Sapir U. Metser G. Flusser et al. Assessment of malignant skeletal disease: Initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT J Nucl Med 45 2004 272-278
34. R. Bar-Shalom N. Yefremov L. Guralnik et al. Clinical performance of PET/ CT in evaluation of cancer: Additional value for diagnostic imaging and patient management J Nucl Med 44 2003 1200-1209
35. G. Antoch N. Saoudi H. Kuehl et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-d-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: Comparison with CT and PET J Clin Oncol 22 2004 4357-4368
36. Department of Health. A framework for the development of positron emission tomography (PET) services in England 2004 www.dh.gov.uk Accessed April 2005.